Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at < 33 wk gestational age: Results from a follow-up of a randomized controlled trial

American Journal of Clinical Nutrition

Volumn 103, Issue 1, 2016, Pages 268-275

  Molloy, Carly S ^a   Stokes, Sacha ^a,b   Makrides, Maria ^d,e,f,g   Collins, Carmel T ^d,e,f,g   Anderson, Peter J ^a,b   Doyle, Lex W ^a,b,c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

^d Women's and Children's Health Research Institute   (Australia)

^e SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

DHA; Docosahexaenoic acid; Preterm infant; Very preterm; Visual processing

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID;

ARTICLE; BENTON JUDGMENT OF LINE ORIENTATION; BIRTH WEIGHT; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; FREIBURG VISUAL ACUITY TEST; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MILK; MULTICENTER STUDY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; STEREOSCOPIC VISION; VISION; VISION TEST; VISUAL ACUITY; DIET; DIETARY SUPPLEMENT; DRUG EFFECTS; FORTIFIED FOOD;

CHILD; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; FOLLOW-UP STUDIES; FOOD, FORTIFIED; GESTATIONAL AGE; HUMANS; INFANT, PREMATURE; MALE; VISION, OCULAR; VISUAL ACUITY; VISUAL PERCEPTION;

EID: 84953889322     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.114710     Document Type: Article

References (81)

1. Molloy CS, Wilson-Ching M, Anderson VA, Roberts G, Anderson PJ, Doyle LW; Victorian Infant Collaborative Study Group. Visual processing in adolescents born extremely low birth weight and/or ex-tremely preterm. Pediatrics 2013;132:e704-12.
2. Evensen KAI, Lindqvist S, Indredavik MS, Skranes J, Brubakk A-M, Vik T. Do visual impairments affect risk of motor problems in preterm and term low birth weight adolescents? Eur J Paediatr Neurol 2009;13: 47-56.
3. Stephenson T, Wright S, O'Connor AR, Fielder AR, Johnson A, Ratib S, Tobin M. Children born weighing less than 1701 g: visual and cognitive outcomes at 11-14 years. Arch Dis Child Fetal Neonatal Ed 2007;92:F265-70.
4. Cooke RW, Foulder-Hughes L, Newsham D, Clarke D. Ophthalmic impairment at 7 years of age in children born very preterm. Arch Dis Child Fetal Neonatal Ed 2004;89:F249-53.
5. Powls A, Botting N, Cooke RW, Stephenson G, Marlow N. Visual impairment in very low birthweight children. Arch Dis Child Fetal Neonatal Ed 1997;76:F82-7.
6. Davis DW, Burns BM, Wilkerson SA, Steichen JJ. Visual perceptual skills in children born with very low birth weights. J Pediatr Health Care 2005;19:363-8.
7. Härd AL, Niklasson A, Svensson E, Hellstrom A. Visual function in school-aged children born before 29 weeks of gestation: a population-based study. Dev Med Child Neurol 2000;42:100-5.
8. Grisham D, Powers M, Riles P. Visual skills of poor readers in high school. Optometry 2007;78:542-9.
9. Maples WC. Visual factors that significantly impact academic perfor-mance. Optometry 2003;74:35-49.
10. Cioni G, Bertuccelli B, Boldrini A, Canapicchi R, Fazzi B, Guzzetta A, Mercuri E. Correlation between visual function, neurodevelopmental outcome, and magnetic resonance imaging findings in infants with periventricular leucomalacia. Arch Dis Child Fetal Neonatal Ed 2000; 82:F134-40.
11. Eken P, de Vries LS, van der Graaf Y, Meiners LC, van Nieuwenhuizen O. Haemorrhagic-ischaemic lesions of the neonatal brain: correlation between cerebral visual impairment, neurodevelopmental outcome and MRI in infancy. Dev Med Child Neurol 1995;37:41-55.
12. Ricci D, Romeo DM, Gallini F, Groppo M, Cesarini L, Pisoni S, Serrao F, Papacci P, Contaldo I, Perrino F, et al. Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 months. Early Hum Dev 2011; 87:177-82.
13. Kushner BJ. Strabismus and amblyopia associated with regressed ret-inopathy of prematurity. Arch Ophthalmol 1982;100:256-61.
14. Nissenkorn I, Yassur Y, Mashkowski D, Sherf I, Ben-Sira I. Myopia in premature babies with and without retinopathy of prematurity. Br J Ophthalmol 1983;67:170-3.
15. Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA; Cryotherapy for Ret-inopathy of Prematurity Cooperative Group. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Ophthalmology 1998;105:1292-300.
16. Molloy CS, Anderson PJ, Anderson VA, Doyle LW. The long-term outcome of extremely preterm (, 28 weeks' gestational age) infants with and without severe retinopathy of prematurity. J Neuropsychol 2015 Mar 24 (Epub ahead of print; DOI: 10.1111/jnp.12069).
17. Buksh MJ, Dai S, Kuschel CA. AP-ROP in an infant with minimal oxygen exposure. J Paediatr Child Health 2008;44:228-30.
18. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996;31(Suppl):S193-7.
19. Niu SL, Mitchell DC, Litman BJ. Optimization of receptor-G protein coupling by bilayer lipid composition II: formation of metarhodopsin II-transducin complex. J Biol Chem 2001;276:42807-11.
20. Aveldaño MI. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 1988;27:1229-39.
21. Bush RA, Malnoe A, Reme CE, Williams TP. Dietary deficiency of n-3 fatty acids alters rhodopsin content and function in the rat retina. Invest Ophthalmol Vis Sci 1994;35:91-100.
22. Volpe JJ. The encephalopathy of prematurity-brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol 2009; 16:167-78.
23. Brand A, Bauer NG, Hallott A, Goldbaum O, Ghebremeskel K, Reifen R, Richter-Landsberg C. Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes up-regulation of heme oxygenase-1 (HSP32). J Neurochem 2010;113:465-76.
24. van Meeteren ME, Baron W, Beermann C, Dijkstra CD, van Tol EAF. Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells. Dev Neurosci 2006;28:196-208.
25. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:121-9.
26. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-38.
27. Uauy R, Mena P, Rojas C. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc 2000;59:3-15.
28. Birch E, Birch DG, Hoffman D, Hale L, Everett M, Uauy RD. Breast-feeding and optimal visual development. J Pediatr Ophthalmol Strabismus 1993;30:33-8.
29. Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual-acuity de-velopment in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993;58:35-42.
30. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast-and formula-fed infants. Am J Clin Nutr 1994;60:189-94.
31. Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003;8:449-59.
32. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing en-terocolitis in very low birth weight infants. J Perinatol 2007;27:428-33.
33. Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003;157:66-71.
34. Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, Poole WK; Neonatal Research Network. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006;118:e115-23.
35. Smithers LG, Gibson RA, McPhee A, Makrides M. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. Am J Clin Nutr 2008;88:1049-56.
36. Makrides M, Gibson RA, McPhee J. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexanoic acid: a randomized controlled trial. JAMA 2009;301:175-82.
37. Henriksen C, Haugholt K, Lindgren M, Aurvag AK, Ronnestad A, Gronn M, Solberg R, Moen A, Nakstad B, Berge RK, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008;121:1137-45.
38. Makrides M, Neumann MA, Gibson RA. Effect of maternal docosa-hexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996;50:352-7.
39. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukot Essent Fatty Acids 2008;79:141-6.
40. Smithers LG, Collins CT, Simmonds LA, Gibson RA, McPhee A, Makrides M. Feeding preterm infants milk with a higher dose of do-cosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010;91:628-34.
41. Collins CT, Gibson RA, Anderson PJ, McPhee AJ, Sullivan TR, Gould JF, Ryan P, Doyle LW, Davis PG, McMichael JE, et al. Neuro-developmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial. BMJ Open 2015;5:e007314.
42. Manley BJ, Makrides M, Collins CT, McPhee AJ, Gibson RA, Ryan P, Sullivan TR, Davis PG, Committee DS. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011;128:e71-7.
43. Wilson-Ching M, Pascoe L, Doyle LW, Anderson PJ. Effects of cor-recting for prematurity on cognitive test scores in childhood. J Paediatr Child Health 2014;50:182-8.
44. Bach M. The Freiburg Visual Acuity Test: automatic measurement of visual acuity. Optom Vis Sci 1996;73:49-53.
45. Bach M. The Freiburg Visual Acuity Test-variability unchanged by post-hoc re-analysis. Graefes Arch Clin Exp Ophthalmol 2007;245:965-71.
46. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities "hand motion" and "counting fingers" can be quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci 2006;47:1236-40.
47. Loumann Knudsen L. Visual acuity testing in diabetic subjects: the decimal progression chart versus the Freiburg Visual Acuity Test. Graefes Arch Clin Exp Ophthalmol 2003;241:615-8.
48. Neargarder SA, Stone ER, Cronin-Golomb A, Oross S III. The impact of acuity on performance of four clinical measures of contrast sensitivity in Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci 2003; 58:54-62.
49. Jongmans M, Mercuri E, Henderson S, de Vries L, Sonksen P, Dubowitz L. Visual function of prematurely born children with and without perceptual-motor difficulties. Early Hum Dev 1996; 45:73-82.
50. McGinnity FG, Bryars JH. Controlled study of ocular morbidity in school children born preterm. Br J Ophthalmol 1992;76:520-4.
51. Elliott DB, Sanderson K, Conkey A. The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Physiol Opt 1990;10: 21-4.
52. Lovie-Kitchin JE, Brown B. Repeatability and intercorrelations of standard vision tests as a function of age. Optom Vis Sci 2000;77:412-20.
53. Shah MB, Fishman GA, Alexander KR, Viana M. Stereoacuity testing in patients with retinal and optic nerve disorders. Doc Ophthalmol 1995;91:265-71.
54. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment: a clinical manual. Oxford (United Kingdom): Oxford University Press; 1994.
55. Martin N. Test of visual perceptual skills. 3rd ed. Novato (CA): Aca-demic Therapy Publications; 2006.
56. Merigan WH, Maunsell JH. Macaque vision after magnocellular lateral geniculate lesions. Vis Neurosci 1990;5:347-52.
57. Mitchell AS, Baxter MG, Gaffan D. Dissociable performance on scene learning and strategy implementation after lesions to magnocellular mediodorsal thalamic nucleus. J Neurosci 2007;27:11888-95.
58. Tanaka D Jr. Thalamic projections of the dorsomedial prefrontal cortex in the rhesus monkey (Macaca mulatta). Brain Res 1976;110:21-38.
59. Wheeler TG, Benolken RM, Anderson RE. Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science 1975;188:1312-4.
60. Lamptey MS, Walker BL. Learning behavior and brain lipid composition in rats subjected to essential fatty acid deficiency during gestation, lactation and growth. J Nutr 1978;108:358-67.
61. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986;83: 4021-5.
62. Birch EE, Birch DG, Hoffman DR, Uauy RD. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992; 33:3242-53.
63. Birch EE, Carlson SE, Hoffman DR, Fitzgerald-Gustafson KM, Fu VLN, Drover JR, Castaneda YS, Minns L, Wheaton DKH, Mundy D, et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010;91: 848-59.
64. Carlson SE, Ford AJ, Werkman SH, Peeples JM, Koo WW. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res 1996;39:882-8.
65. Hoffman DR, Birch EE, Castaneda YS, Fawcett SL, Wheaton DH, Birch DG, Uauy RD. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 2003;142:669-77.
66. Makrides M, Neumann M, Simmer K, Pater J, Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995;345:1463-8.
67. O'Connor DL, Hall R, Adamkin D, Auestad N, Castillo M, Connor WE, Connor SL, Fitzgerald K, Groh-Wargo S, Hartmann EE, et al. Growth and development in preterm infants fed long-chain poly-unsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001;108:359-71.
68. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res 1990;28:485-92.
69. Madan A, Jan JE, Good WV. Visual development in preterm infants. Dev Med Child Neurol 2005;47:276-80.
70. Backus BT, Fleet DJ, Parker AJ, Heeger DJ. Human cortical activity correlates with stereoscopic depth perception. J Neurophysiol 2001;86: 2054-68.
71. Nishida Y, Hayashi O, Iwami T, Kimura M, Kani K, Ito R, Shiino A, Suzuki M. Stereopsis-processing regions in the human parieto-occipital cortex. Neuroreport 2001;12:2259-63.
72. Schechter I, Butler PD, Jalbrzikowski M, Pasternak R, Saperstein AM, Javitt DC. A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia. Biol Psychiatry 2006;60:1282-4.
73. Ahmad A, Moriguchi T, Salem N. Decrease in neuron size in docosa-hexaenoic acid-deficient brain. Pediatr Neurol 2002;26:210-8.
74. Stein J. The magnocellular theory of developmental dyslexia. Dyslexia 2001;7:12-36.
75. Shimazawa M, Nakajima Y, Mashima Y, Hara H. Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res 2009;1251:269-75.
76. Rotstein NP, Aveldano MI, Barrantes FJ, Politi LE. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J Neurochem 1996;66:1851-9.
77. Hamilton R, Bradnam MS, Dudgeon J, Mactier H. Maturation of rod function in preterm infants with and without retinopathy of prematurity. J Pediatr 2008;153:605-11.
78. Westerberg AC, Schei R, Henriksen C, Smith L, Veierod MB, Drevon CA, Iversen PO. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 2011;100:47-52.
79. Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 1992;33:2365-76.
80. Carlson SE, Werkman SH, Tolley EA. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 1996;63:687-97.
81. Makrides M. DHA supplementation during the perinatal period and neurodevelopment: do some babies benefit more than others? Prosta-glandins Leukot Essent Fatty Acids 2013;88:87-90.